158 related articles for article (PubMed ID: 34390698)
41. Neuroimaging of phakomatoses: overview and advances.
Vézina G
Pediatr Radiol; 2015 Sep; 45 Suppl 3():S433-42. PubMed ID: 26346149
[TBL] [Abstract][Full Text] [Related]
42. Pathophysiology and management of glaucoma associated with phakomatoses.
Thavikulwat AT; Edward DP; AlDarrab A; Vajaranant TS
J Neurosci Res; 2019 Jan; 97(1):57-69. PubMed ID: 29607552
[TBL] [Abstract][Full Text] [Related]
43. Newborns of mothers with intellectual disability have a higher risk of perinatal death and being small for gestational age.
Höglund B; Lindgren P; Larsson M
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1409-14. PubMed ID: 22924821
[TBL] [Abstract][Full Text] [Related]
44. Preterm and postterm birth in immigrant- and Swedish-born parents: a population register-based study.
Khanolkar AR; Wedrén S; Essén B; Sparén P; Koupil I
Eur J Epidemiol; 2015 May; 30(5):435-47. PubMed ID: 25687167
[TBL] [Abstract][Full Text] [Related]
45. Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1.
Rerat K; Parker F; Nasser G; Vidaud D; Riant F; Tournier-Lasserve E; Denier C
J Neurol Sci; 2015 Mar; 350(1-2):98-100. PubMed ID: 25702150
[TBL] [Abstract][Full Text] [Related]
46. The pregnancy in neurofibromatosis 1: A retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Timonen S; Peltonen J; Peltonen S
Am J Med Genet A; 2017 Oct; 173(10):2641-2648. PubMed ID: 28815922
[TBL] [Abstract][Full Text] [Related]
47. Preterm birth and psychiatric disorders in young adult life.
Nosarti C; Reichenberg A; Murray RM; Cnattingius S; Lambe MP; Yin L; MacCabe J; Rifkin L; Hultman CM
Arch Gen Psychiatry; 2012 Jun; 69(6):E1-8. PubMed ID: 22660967
[TBL] [Abstract][Full Text] [Related]
48. Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.
Doser K; Kenborg L; Andersen EW; Bidstrup PE; Kroyer A; Hove H; Østergaard J; Sørensen SA; Johansen C; Mulvihill J; Winther JF; Dalton SO
Eur J Hum Genet; 2019 Jun; 27(6):857-868. PubMed ID: 30820037
[TBL] [Abstract][Full Text] [Related]
49. Recent advances in the phakomatises.
Person JR; Perry HO
Int J Dermatol; 1978; 17(1):1-13. PubMed ID: 415011
[No Abstract] [Full Text] [Related]
50. [Pulmonary changes in patients with type I neurofibromatosis and tuberous sclerosis].
Ljubić S; Peros-Golubicić T
Lijec Vjesn; 1993; 115(3-4):95-8. PubMed ID: 8231624
[TBL] [Abstract][Full Text] [Related]
51. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
52. Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic population- and register-based case-control study.
Schmidt LS; Schüz J; Lähteenmäki P; Träger C; Stokland T; Gustafson G; Hjalgrim L; Sehested A; Johansen C; Schmiegelow K
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1042-52. PubMed ID: 20332267
[TBL] [Abstract][Full Text] [Related]
53. Cutaneous manifestations in neuro-oncology: clinically relevant tumor and treatment associated dermatologic findings.
Strowd RE; Strowd LC; Blakeley JO
Semin Oncol; 2016 Jun; 43(3):401-7. PubMed ID: 27178695
[TBL] [Abstract][Full Text] [Related]
54. Neurocutaneous syndromes in the M kindred; a case of simultaneous occurrence of tuberous sclerosis an neurofibromatosis.
SCHULL WJ; CROWE FW
Neurology; 1953 Dec; 3(12):904-9. PubMed ID: 13154572
[No Abstract] [Full Text] [Related]
55. Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.
Terry AR; Jordan JT; Schwamm L; Plotkin SR
Stroke; 2016 Jan; 47(1):60-5. PubMed ID: 26645253
[TBL] [Abstract][Full Text] [Related]
56. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.
Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC
Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788
[TBL] [Abstract][Full Text] [Related]
57. Neurofibromatosis I and multiple sclerosis.
Bergqvist C; Hemery F; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2020 Jul; 15(1):186. PubMed ID: 32664938
[TBL] [Abstract][Full Text] [Related]
58. Hypohidrosis in the macules in tuberous sclerosis complex and neurofibromatosis.
Koguchi-Yoshioka H; Tanemura A; Katayama I; Fujimoto M; Wataya-Kaneda M
J Dermatol; 2021 Mar; 48(3):418-419. PubMed ID: 33368630
[No Abstract] [Full Text] [Related]
59. The cystic renal lesion in tuberous sclerosis.
Stapleton FB; Johnson D; Kaplan GW; Griswold W
J Pediatr; 1980 Oct; 97(4):574-9. PubMed ID: 7420220
[TBL] [Abstract][Full Text] [Related]
60. Neurocutaneous syndromes in children.
Chalhub EG
Pediatr Clin North Am; 1976 Aug; 23(3):499-516. PubMed ID: 822387
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
